Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

Autor: Dormandy JA (AUTHOR), Charbonnel B (AUTHOR), Eckland DJA (AUTHOR), Erdmann E (AUTHOR), Massi-Benedetti M (AUTHOR), Moules IK (AUTHOR), Skene AM (AUTHOR), Tan MH (AUTHOR), Lefèbvre PJ (AUTHOR), Murray GD (AUTHOR), Standl E (AUTHOR), Wilcox RG (AUTHOR), Wilhelmsen L (AUTHOR), Betteridge J (AUTHOR), Birkeland K (AUTHOR), Golay A (AUTHOR), Heine RJ (AUTHOR), Korányi L (AUTHOR), Laakso M (AUTHOR), Mokán M (AUTHOR)
Zdroj: Lancet. 10/8/2005, Vol. 366 Issue 9493, p1279-1289. 11p.
Databáze: Academic Search Ultimate